Results
1 -
10 of
10
(Click
here to explore results)
- Neglected Diseases and Drug Discovery, Chapter 1 Malaria: New Medicines for its Control and Eradication. Timothy N. C. Wells, Winston E. Gutteridge
, 2012
, Pages 1-32
- UHPLC in Life Sciences, Chapter 9 UHPLC in Modern Bioanalysis. Lucie Nováková
, 2012
, Pages 237-282
- Specialised Pharmaceutical Formulation: The Science and Technology of Dosage Forms, Chapter 10 Development Programs for Oral Fixed Dose Combination Products. Patrick J. Crowley, Sharon M. Maglennon, Luigi G. Martini, David Templeton
, 2022
, Pages 259-286
- Neglected Diseases and Drug Discovery, Chapter 2 Semisynthetic Artemisinin and Synthetic Peroxide Antimalarials. Leann Tilley, Susan A. Charman, Jonathan L. Vennerstrom
, 2012
, Pages 33-64
- Antibiotic Drug Discovery: New Targets and Molecular Entities, CHAPTER 8 Antibacterial Leads Targeting Isoprenoid Biosynthesis. Carl J. Balibar
, 2017
, Pages 204-255
- Traditional Chinese Medicine: Scientific Basis for Its Use, Chapter 6 Modern Drug Discovery from Chinese Materia Medica Used in Traditional Chinese Medicine. Kuo-Hsiung Lee*, Susan L. Morris-natschke, Joshua Brattlie, Jingxi Xie, Eileen Belding
, 2013
, Pages 81-134
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Chapter 6 Quinolines: Privileged Scaffolds in Medicinal Chemistry. Arantxa Encinas López
, 2016
, Pages 132-146
- Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation, Subject Index
, 2016
, Pages 459-468
- UHPLC in Life Sciences, Subject Index
, 2012
, Pages 429-447
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80